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iaobin2005@hotmAbstract This study focuses on the preparation and enzymic hydrolysis of an icariin/b-
cyclodextrin inclusion complex to efﬁciently generate icaritin. The physical characteristics of the
inclusion complex were evaluated by differential scanning calorimetry (DSC). Enzymatic hydrolysis
was optimized for the conversion of icariin/b-cyclodextrin complex to icaritin by Box–Behnken
statistical design. The inclusion complex formulation increased the solubility of icariin approxi-
mately 17-fold, from 29.2 to 513.5 mg/mL at 60 1C. The optimum conditions were predicted by
Box–Behnken statistical design as follows: 60 1C, pH 7.0, the ratio of enzyme/substrate (1:1.1) and
reaction time 7 h. Under the optimal conditions the conversion of icariin was 97.91% and the
reaction time was decreased by 68% compared with that without b-CD inclusion. Product analysis
by melting point, ESI-MS, UV, IR, 1H NMR and 13C NMR conﬁrmed the authenticity of icaritin
with a purity of 99.3% and a yield of 473 mg of icaritin from 1.1 g icariin.
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Figure 1 Schematic representation of the b-cyclodextrin molecule.
Xin Jin et al.841. Introduction
Herba Epimedii, which is derived from the aerial parts of
Epimedium brevicornum, E. sagittatum, E. pubescens, E. wush-
anense and E. koreanum, is a well-known traditional Chinese
medicine1. The main constituents of Herba Epimedii are reported
to be ﬂavonoids2, including icariin3 and icaritin (Scheme 1).
Pharmacological studies showed that icaritin, the aglycone
of icariin, enhanced the differentiation and proliferation of
osteoblasts4 and facilitated matrix calciﬁcation5. It also inhib-
ited human prostate carcinoma PC-3 cells growth6 and had
inhibitory effects on the proliferation of breast cancer cells7.
Nevertheless, the amount of icaritin in Herba Epimedii is very
low, and so the preparation of ample quantities for pharma-
cological studies is a challenge.
Acid hydrolysis is a common method for preparation of
aglycone from glycosides; however, this method requires strict
conditions, gives low yields, numerous byproducts and con-
tributes to environmental pollution8,9. Indeed, the yield of
icaritin from icariin by this technique is poor10. Enzyme
hydrolysis is widely used for the selective preparation of
aglycones from glycosides; hesperidinase and nariginase have
been used for this purpose11–13. At least one group used
snailase to prepare icaritin; Jia et al.14 found that 48 h was
necessary to produce icaritin under the optimum enzymolysis
conditions, with a yield of 92%. However, the time required
for the enzymatic reaction was relatively long. The reason for
the result in this study may be the low solubility of icariin in
water15, which restricted the speed of enzyme hydrolysis.
There are a number of methods used in enzyme hydrolysis,
such as promoting the activity of enzymes at high pressure16
and processing on immobilized biocatalysts17. The immobi-
lized enzymes generally present mass transfer limitations and
showed lower catalytic activity due to reduced substrate
transfer resistance18. High pressure added to the process cost.
Therefore, these methods were not efﬁcient with poorly water-
soluble substrates. Finding an approach to increase conversion
efﬁciency by enhancing the aqueous solubility of poorly water-
soluble substrates seems necessary and important.
b-cyclodextrin (b-CD, Fig. 1) is a circular molecule linked by
a-1,4-bonds. Hydrophilic outer tails and hydrophobic inner
cavities allow b-CD to easily form an inclusion complex with a
diversity of molecules to increase their solubility19–21. In the
pharmaceutical industry b-CD has often been used to enhance
the solubility of drugs such as isoproturon22, celecoxib23 and manyScheme 1 Snailase-catalyzed transformation ofother hydrophobic drugs24,25, suggesting to us that icariin/b-CD
inclusion complex may improve solubility of icariin and conse-
quently increase the enzymatic hydrolysis rate of icariin to icaritin.
So far, few papers have reported on enzymatic hydrolysis of
b-CD inclusion complexes targeting compound preparation
using response surface methodology. The aim of this study
was to form an inclusion complex to increase the solubility of
icariin and test its use for the preparation of icaritin by
enzymatic hydrolysis of icariin/b-CD inclusion complex.2. Experimental
2.1. Apparatus
The analysis was carried out with an Agilent 1100 HPLC
system (Agilent, USA), which consists of an auto sample
injection (G1313A), QuatPump (G1311A), column component
(G1316A) and photodiode array detector (G1315A). Agilent
ChemStation Software (Rev.B.03.02) was used to analyze
the data. Enzymatic hydrolysis was carried out in a digital
temperature air bath oscillator (Jintan Shuangjie Experimental
Instrument Factory, China). A TGL-16H high-speed centrifugeicariin/b-CD inclusion complex to icaritin.
Table 1 Response surface analysis of factors and levels.
Level Temperature
(1C)
pH Reaction
time (h)
Enzyme/
substrate
þ1 50 5 3 1:2
0 60 7 7 1:1
1 70 9 11 3:2
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prepare the samples.
2.2. Materials and reagents
Acetonitrile and methanol were of chromatographic grade
(TEDIA, UN). All other reagents were of analytical grade.
Ultra-pure water was prepared with Milli-Q water system
(Bedford, MA). b-cyclodextrin (average molecular weight:
1135) was purchased from Shanghai Chemical Reagent Com-
pany of China Pharmaceutical Group. Snailase was purchased
from Baier Di Biotechnology Co., Ltd. Icariin (purity498%)
and icaritin (purity498%) were provided by the Laboratory
of Pharmaceutical Preparation (Jiangsu Provincial Academy
of Chinese Medicine, China).
2.3. Preparation of the icariin/b-cyclodextrin inclusion
complex
The inclusion complex of icariin with b-cyclodextrin at a
1:1 molar ratio was prepared using the dropping method.
b-Cyclodextrin was dissolved in distilled water until the
solution was saturated. Then icariin, dissolved in 50% (v/v)
ethanol, was added to the saturated b-CD solution drop by
drop. The suspension was stirred at 60 1C for 12 h. After
standing overnight at 4 1C the suspension was ﬁltered and un-
included drug was removed from the preparation with a 50%
(v/v) ethanol wash. The ﬁnal icariin-b-CD complex was
lyophilized for use.
2.4. Determination of icariin and icariin/b-CD inclusion
complex solubility
An excess amount of icariin and icariin/b-CD inclusion complex
was added to water and the solution was stirred using a magnetic
stirrer for 24 h at 6070.1 1C, after which the solution was
allowed to settle for 2 h. The supernatant liquid was taken and
ﬁltered through a 0.45 mm membrane (Chuangwei, China).
The ﬁrst 15% of the ﬁltrate was discarded to avoid any
potential loss of the drug due to absorption by the ﬁlter and
the subsequent ﬁltrate was collected. All procedures were
conducted at 6070.1 1C to avoid precipitation of the drug26.
A 20 mL aliquot of the resulting solution was analyzed by
HPLC in triplicate.
2.5. Differential scanning calorimetry (DSC)
Samples were sealed in aluminum crimp cells and heated at a
rate of 10 1C/min from 30 to 450 1C under nitrogen (DSC-60,
Shi-Madzu, Japan). The peak transition maximum tempera-
tures of b-CD, pure icariin, the mixture of b-CD and icariin
and icariin/b-CD inclusion complexes were compared using a
Thermal Analyzer (TA-60WS, Shi-Madzu, Japan).
2.6. Experimental design and analysis
The icariin/b-CD inclusion complex was dissolved in 10 mL
distilled water in a 10 mL microcentrifuge tube using a digital
temperature air bath oscillator at a constant speed of 100 rpm.
For enzymatic hydrolysis of the icariin/b-CD inclusion com-
plex the following factors were considered: pH, temperature,the ratio of enzyme/substrate and reaction time. All samples
were tested in triplicate. The Box–Behnken statistical design27
was used to optimize these reaction factors, as shown in
Table 1. To predict the optimal point, the experimental results
were ﬁtted to a second-order polynomial function for four
factors, using the following equation:
Y ¼ b0 þ b1X1 þ b2X2 þ b3X3 þ b4X4 þ b12X1X2 þ b13X1X3
þb14X1X4 þ b23X2X3 þ b24X2X4 þ b34X3X4 þ b11X21
þb22X22 þ b33X23 þ b44X24 ð1Þ
where Y is the predicted response, b0 is the model constant, X1,
X2, X3 and X4 are independent variables, b1, b2, b3 and b4 are
linear coefﬁcients, b12, b13, b14, b23, b24 and b34 are cross-
product coefﬁcients, and b11, b22, b33 and b44 are the quadratic
coefﬁcients.
2.7. Puriﬁcation and analysis of icaritin
Icaritin was generated from the inclusion complex using the
optimized conditions for enzymatic hydrolysis. The produced
icaritin was extracted from the reaction mixture with ethyl
acetate. Subsequently, icaritin was dissolved in methanol and
subjected to silica gel column chromatography using CHCl3–
MeOH for elution. Fractions containing pure icaritin were
combined and icaritin was recovered by drying under reduced
pressure. Identity and purity were conﬁrmed by melting point,
ESI-MS, UV, IR, 1H NMR and 13C NMR analyses.
2.8. HPLC analysis of icaritin production
Separation was achieved on an Agilent ZORBAX SB-C18
(4.6 mm 250 mm, 5 mm) column maintained at 30 1C. The
mobile phase consisted of water (A) and acetonitrile (B) with
linear gradient elution: 0–7 min, 38% B; 7–8 min, 75% B;
8–20 min, 75% B; 20–30 min, 38% B. The ﬂow rate was
1.0 mL/min. The wavelength of detector was set at 270 nm.
Due to the variation in the content of icariin and icaritin in the
samples, the stock solutions of standards were prepared and
diluted with methanol solution for the establishment of calibra-
tion curves. Seven concentrations of icariin and icaritin solutions
were injected in triplicate. The calibration curves were constructed
by plotting the peak areas against the concentration of each
analyte. An aliquot of 20 mL from samples were injected into
HPLC and the content of icariin and icaritin was calculated using
the calibration curves. Precision and accuracy were also tested.
2.9. Calculation of the conversion rate
Sample solutions (100 mL each) were extracted with 900 mL of
methanol, vortexed for 30 s and then collected by centrifugation
Xin Jin et al.86at 11,000 rpm for 15 min. The supernatant (20 mL) was injected
into HPLC. The conversion rate was calculated using following
equation:
Conversion rate ð%Þ ¼ ½CV=ðm2 M1=M2Þ  100% ð2Þ
where C is the concentration of icaritin, V is the volume of
icaritin, M1 is the molecular weight of icaritin, M2 is the
molecular weight of icariin and m2 is the weight of icariin.Figure 2 DSC thermograms of icariin (a), b-CD (b), physical
mixture (c) and icariin/b-CD inclusion compounds (d).3. Results and discussion
The use of enzymolysis to prepare an active component is of
current interest in traditional Chinese medicines. Snailase, an
enzyme mixture extracted from the crop and enteron of snails,
contains cellulase, pectinase, amylase, protease and other lytic
enzymes28 and is widely used in food processing, cell biology
and genetic engineering29,30. Snailase will also hydrolyze
glycosides to aglycones; however, few examples of this have
been reported in traditional Chinese medicines. In this article
the optimum conditions for the bioconversion of an icariin/
b-cyclodextrin inclusion complex to icaritin using snailase and
the Box–Behnken statistical design were obtained.Figure 3 Effect of substrate:enzyme ratio on hydrolysis efﬁciency3.1. Analytical method validation
The analytical method was validated in terms of linearity,
precision and accuracy; the calibration curve values are as
follows: icariin, A¼22,543Cþ29.746 (r¼0.9997), with a linear
range of 15.25–1344.2 mg/mL; icaritin, A¼22,602Cþ807.96
(r¼0.9994), with a linear range of 12.31–1107.9 mg/mL. The
precision (RSDo5%) and accuracy (RSDo5%) showed that
the HPLC method is precise and accurate enough for the
quantitative determination of icariin and icaritin in samples.of snailase. Substrate was mixed with 5, 10, 20, 50, 100 and
200 mg of snailase (enzyme:substrate¼1:20, 1:10, 1: 5, 1:2, 1:1 and
2:1), respectively. Distilled water was added to the mixture at a
ﬁnal volume of 10 mL. The mixture was incubated at 37 1C for
3 h. Values are expressed as mean7SD, n¼3.3.2. Solubility of icariin and icariin/b-CD inclusion
compounds
The water solubility of the icariin/b-CD inclusion complex was
higher than that of free icariin. The solubility of icariin
increased almost 17-fold from 29.2 to 513.5 mg/mL at 60 1C,
demonstrating that the inclusion complex could signiﬁcantly
increase the solubility of icariin.3.3. Differential scanning calorimetry (DSC)
Differential scanning calorimetry is a rapid and reliable
strategy to screen compatibility between icariin and b-CD.
Fig. 2 shows the DSC curves of icariin (a), b-CD (b), a
physical mixture (c) and icariin/b-CD inclusion compounds
(d)31,32. The thermogram of icariin exhibits a characteristic
peak (242.1 1C). b-CD exhibits a maximum absorption peak at
315.4 1C. The mixture of icariin and b-CD shows two onset
temperature peaks that correspond to those for icariin
(242.6 1C) and b-CD (310.3 1C). DSC of icariin/b-CD inclu-
sion compounds shows that the endothermal peaks of icariin
disappear, demonstrating the formation of an inclusion com-
plex, which differs from that of the individual compounds and
the physical mixture.3.4. Optimal conditions for enzymatic hydrolysis
3.4.1. Effect of substrate proportion on hydrolysis efﬁciency
of snailase
Hydrolysis of icariin was performed with different concentra-
tions of snailase (Fig. 3). The hydrolysis increased both with
icariin and with icariin/b-CD inclusion. Higher conversion
was obtained at a low enzyme concentration. At the ratio of
1:1 (enzyme/substrate), the increase in hydrolysis was 18.1%
with the inclusion complex compared to the increase of 9.9%
with icariin alone. At all ratios of enzyme/substrate the
conversion to icaritin was lower when inclusion complex was
not formed. For the ratio of enzyme/substrate, the content of
icaritin increased with the rising ratio of snailase/icariin in the
mixture and reached its maximum at 1:1. Therefore, the ratio
of enzyme/substrate (1:1) was the optimum proportion.
3.4.2. Effect of pH on efﬁciency of snailase hydrolysis
Fig. 4 shows that for icariin, the optimal pH was 7.0; this
differs from the results obtained with arctiin and chitosan33,34.
Figure 4 Effect of pH on hydrolytic efﬁciency of snailase. The
reaction mixture contained icariin/b-CD inclusion complex
(100 mg of icariin), snailase (100 mg) and glacial acetic acid
sodium acetate anhydrous buffer (10 mL, pH 4.5, 5.0, 5.5, 6.0, 6.5
and 7.0). The mixture was incubated at 37 1C for 3 h. Values are
expressed as mean7SD, n¼3.
Figure 5 Effect of temperature on the snailase-catalyzed hydro-
lysis. The reaction mixture contained icariin/b-CD inclusion
complex (containing 100 mg icariin), snailase (100 mg) and dis-
tilled water (10 mL), and was incubated at 25, 37, 50, 60 and 70 1C
for 3 h. Values are expressed as mean7SD, n¼3.
Figure 6 Effect of reaction time on hydrolysis. The reaction
mixture contained substrate, snailase (100 mg) and distilled water
(10 mL). It was incubated at 60 1C for 3, 4, 5, 6, 7 and 8 h. Values
are expressed as mean7SD, n¼3.
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mixture, which includes cellulase, pectinase, amylase, protease
and other enzymes. Moreover, the pH 7.0 was probably not
the optimal pH for all the enzymes contained in snailase. This
also shows that the conversion to icaritin increased remark-
ably when the inclusion complex was formed. The conversion
to icaritin with the inclusion complex reached a maximum
value of 20.1% (in 3 h reaction) when the buffer pH was 7.0
and the transformation rate increased by more than 100%.
When icariin was included within b-CD, the solubility was
signiﬁcantly enhanced, which may explain the increased
transformation rate.
3.4.3. Effect of temperature on the snailase catalyzed
hydrolysis
The optimal temperatures are different among various sub-
strates of snailase. It hydrolyzed ginsenoside-Rb1 and chitin at
40 1C35 and 25 1C36, respectively. In this study, 60 1C was
most suitable for the reaction, as demonstrated in Fig. 5. Theconversion to icaritin increased remarkably when the reaction
temperature was increased from 25 1C, and reached its max-
imum at 60 1C, then decreased slowly with increasing tem-
perature. A temperature of 60 1C was optimal for snailase
both with icariin alone or the inclusion. At 60 1C, the activity
of the snailase with the inclusion was signiﬁcantly superior to
the snailase with icariin alone. The conversion was increased
by almost 125% (from 24.5% to 55.2%).
3.4.4. Effect of reaction time on hydrolysis
Icariin was hydrolyzed by the snailase in isolation and in
complex with b-CD (Fig. 6). Substantial hydrolysis over the
7-h time-course was obtained with both icariin reaction
systems at a relatively constant rate. The conversion was also
superior with the inclusion complex as compared to that of
icariin alone. After 3 h, the conversion was increased by
almost 125% (from 24.5% to 55.2%), and after 7 h, it was
increased by 68% (from 58.4% to 97.9%). The best reaction
time is 7 h according to the result (Fig. 6). Therefore, the
reaction time of icariin hydrolysis to icaritin was signiﬁcantly
shorter than that reported in the literatures12,14.
3.4.5. Process optimization
According to the results of the optimization study, the ratio of
enzyme/substrate (1:1), pH of 7.0, temperature of 60 1C and
reaction time of 7 h were chosen as the conditions of the Box–
Behnken statistical design to optimize the production process.
Results were obtained by an HPLC analysis after the reactions
were carried out under the chosen conditions. The analysis
was repeated in triplicate. The coefﬁcients of the response
surface model given in Eq. (1) were evaluated by ﬁtting to the
experimental data, where the responses and variables were
ﬁtted with multiple regressions. Table 2 shows the experi-
mental conditions and results for the icaritin production and
yield according to the factorial design. A good ﬁt was obtained
and no outliers were observed. An analysis of variance
(ANOVA) indicated that the model was highly appropriate
for the prediction, owing to its high F value (54.35) and small
signiﬁcance P value (0.0001). Moreover, a statistical analysis
revealed no lack of ﬁt, and the coefﬁcient of determination (R2) of
the model was 0.9819, indicating an adequate precision and that
the model is suitable for navigating the design space (Table 3).
Table 2 Operating variables, levels and experimental
data used in the Box–Behnken design.
Run Temperature
(1C)
pH Reaction
time (h)
Enzyme/
substrate
Conversion
(%)
1 70 7 7 1:2 59.04
2 60 9 3 1:1 32.57
3 60 7 3 1:2 35.23
4 60 9 7 3:2 71.54
5 60 9 11 1:1 60.84
6 60 7 11 3:2 95.74
7 50 7 7 1:2 42.73
8 60 9 7 1:2 43.64
9 50 7 7 3:2 79.11
10 60 7 11 1:2 51.72
11 60 7 3 3:2 52.96
12 50 9 7 3:2 40.27
13 70 7 11 1:1 76.48
14 60 5 11 1:1 21.67
15 50 5 7 1:1 19.07
16 70 5 7 1:1 19.39
17 70 7 3 1:1 39.37
18 70 7 7 3:2 85.22
19 50 7 11 1:1 63.28
20 60 5 3 1:1 15.08
21 50 7 3 1:1 39.33
22 60 5 7 1:2 17.13
23 60 5 7 3:2 22.29
24 70 9 7 1:1 51.16
25–29 70 7 7 1:1 97.09
Table 3 Analysis of variance for quadratic model.
Source Sum of
squares
df Mean
Square
F-value P-value
Model 22118.24 14 1579.87 54.35 o0.0001
Residual 406.96 14 29.07
Lack of ﬁt 405.05 10 40.51 84.97 o0.0003
Pure error 1.91 4 0.48
R2 0.9819
Table 4 Regression coefﬁcients of variables.
Variable Coefﬁcient
estimate
df Standard
error
Prob4F
b0 97.09 1 2.41
b1 3.91 1 1.56 0.025
b2 15.45 1 1.56 o0.0001
b3 12.93 1 1.56 o0.0001
b4 13.11 1 1.56 o0.0001
b12 2.64 1 2.70 0.3436
b13 3.29 1 2.70 0.2425
b14 2.55 1 2.70 0.3602
b23 5.42 1 2.70 0.0489
b24 5.69 1 2.70 0.0434
b34 6.57 1 2.70 0.0287
b11 19.03 1 2.12 o0.0001
b22 44.00 1 2.12 o0.0001
b33 22.80 1 2.12 o0.0001
b44 13.79 1 2.12 o0.0001
Xin Jin et al.88The statistical analysis also showed that all the four factors had a
signiﬁcant effect on the enzymatic hydrolysis of icariin/b-CD
inclusion compounds into icaritin (Table 4); however, the most
relevant variable (Po0.05) regarding the icaritin yield was the
reaction time (RT). After eliminating the nonsigniﬁcant interac-
tion coefﬁcients (P-value40.05), the reduced model is expressed
as follows:
Y ¼ 97:09þ 3:91X1 þ 15:45X2 þ 12:93X3 þ 13:11X4 þ 5:42X2X3
þ5:69X2X4 þ 6:57X3X4219:03X21244X22222:8X2313:79X24
ð3Þ
where X1, X2, X3 and X4 represent the temperature (1C),
pH, reaction time (h) and the ratio of enzyme/substrate,
respectively.
In addition to the effects of the shown variables on the
icaritin yield, the contour plots also indicated several optimalvariable combinations that can be selected by a manufacturer
to obtain a higher yield. Thus, according to the optimization
based on the contour plots, the recommended conditions were
the ratio of enzyme/substrate (1:1.1), pH (7.0), temperature
(60 1C) and reaction time (7 h), which predicted an icaritin
yield of 98.35%.3.5. Preparation of icaritin under optimum conditions
The time needed to generate icaritin decreased by 85.4% as
compared with that in literature14, with an efﬁciency of up to
97.91%. The inclusion complex of icariin containing 1.13 g of
icariin was mixed with 1.02 g snailase in 100 mL of water in
triplicate. The buffer was subsequently incubated in an HH-4
digital constant temperature water bath at 60 1C for 7 h. The
ﬁnal reaction mixture was extracted with ethyl acetate for three
times, and the combined ethyl acetate fractions were evaporated
to dryness under reduced pressure. HPLC analysis showed that
97.9% of icariin in the inclusion complex was hydrolyzed to
icaritin. To isolate icaritin, the residue was dissolved in 10 mL
methanol and subjected to silica gel column chromatography
using CHCl3–MeOH for elution. Finally, 473 mg of icaritin was
obtained with the purity of 99.3%. The identiﬁcation of icaritin
was carried out by melting point, ESI-MS, UV, IR, 1H NMR
and 13C NMR and compared with the data given in refer-
ences37,38. The results are as follows: yellow needle crystal,
molecular formula: C21H20O6; mp 205–207 1C; ESIMS, m/z
(%): 369 [MþH]þ; UVmax: 270 nm; IR(KBr) nmaxcm1: 3319,
1655, 1603, 1511, 1461, 1385, 1257, 1227, 838; 13C NMR
(DMSO-d6, 100 MHz): d 146.65(C2), 136.39(C3), 176.70(C4),
160.95(C5), 98.30(C6), 161.72(C7), 106.09(C8), 153.99(C9),
103.54(C10), 122.96(C1
0), 129.64(C20), 114.56(C30), 158.77(C40),
114.56(C5
0), 129.64(C60), 55.85(C-OMe) 21.67(Cl00), 124.05(C200),
131.47(C3
00), 25.90(C400), 18.30(C500);
1H NMR (DMSO-d6,
400 MHz): d 12.374(1H, s, C5-OH), 10.737(1H, s, C7-OH),
9.475(1H, s, C3-OH), 8.10(2H, d, J¼8.7 Hz, H-20,60),
7.10(2 H, d, J¼5.7 Hz, H-30,50), 6.306(1H, s, H-6), 5.183(1H,
t, J¼6.7 Hz, H-20), 3.851(3H, s, 40-OMe), 3.433(2H, d, J¼6.7
Hz, H-100), 1.684(3H, s, H-400), 1.61(3H, s, H-500).
Preparation and enzymic hydrolysis of an icariin/b-cyclodextrin 894. Conclusions
The conditions chosen in this study signiﬁcantly increased the
hydrolysis rate and shortened the reaction time for the
generation of icaritin from icariin. The incorporation of icariin
into b-CD complexes increased the solubility of icariin and
without protecting the glycosidic bond from hydrolysis by
snailase. This study clearly demonstrates an improvement in
the speed of enzyme hydrolysis for the preparation of icaritin
from icariin in high yield and suggests that this approach may
be effective with other poorly water-soluble drugs.
Acknowledgments
This work was supported by the National Natural Science
Foundation of China (No. 30973944/H2805) and the founda-
tion for high-level talent on six areas of Jiangsu province.
References
1. The State Pharmacopoeia Committee of China. The Pharmaco-
poeia of the people’s Republic of China. Beijing: China Medical and
Technology Press; 2010, p. 306.
2. Ma H, He X, Yang Y, Li M, Hao D, Jia Z. The genus Epimedium:
an ethnopharmacological and phytochemical review. J Ethnophar-
macol 2011;134:519–41.
3. Qiu F, Chen YJ, Kano YH, Yao XS, et al. Metabolism of orally
administered icariin in rats. Acta Pharm Sin 1999;34:222–6.
4. Zhai YK, Chen KM, Ge BF, Ma HP, Ming LG, Cheng GZ. The
changes of iNOS and NO in the osteogenic differentiation process
of rat bone marrow stromal cells promoted by icariside II. Acta
Pharm Sin 2011;4:383–9.
5. Yap SP, Shen P, Butler MS, Gong Y, Loy CJ, Yong EL. New
estrogenic prenylﬂavone from Epimedium brevicornum inhibits the
growth of breast cancer cells. Planta Med 2005;71:114–9.
6. Huang X, Zhu D, Lou Y. A novel anticancer agent, icaritin,
induced cell growth inhibition, G1 arrest and mitochondrial
transmembrane potential drop in human prostate carcinoma
PC-3 cells. Eur J Pharmacol 2007;564:26–36.
7. Wang ZQ, Lou YJ. Proliferation-stimulating effects of icaritin and
desmethylicaritin in MCF-7 cells. Eur J Pharmacol 2004;504:147–53.
8. Zhang G, Qin L, Sheng H, Wang XL, Wang YX, Yeung DK,
et al. A novel semisynthesized small molecule icaritin reduces
incidence of steroid-associated osteonecrosis with inhibition of
both thrombosis and lipid-deposition in a dose-dependent man-
ner. Bone 2009;44:345–56.
9. Liu DF, Li YP, Ou TM, Huang SL, Gu LQ, Huang M, et al.
Synthesis and antimultidrug resistance evaluation of icariin and its
derivatives. Bioorg Med Chem Lett 2009;19:4237–40.
10. Yi P, Yu P, Li ZQ, Wang YQ. A new method to prepare icaritin.
J Chin Med Mater 2010;33:1804–6.
11. Park JS, Park HY, Rho HS, Ahn S, Kim DH, Chang IS.
Statistically designed enzymatic hydrolysis for optimized produc-
tion of icariside II as a novel melanogenesis inhibitor. J Microbiol
Biotechnol 2008;18:110–7.
12. Dell’Agli M, Galli GV, Dal Cero E, Belluti F, Matera R, Zironi E,
et al. Potent inhibition of human phosphodiesterase-5 by icariin
derivatives. J Nat Prod 2008;71:1513–7.
13. Liu J, Ye H, Lou Y. Determination of rat urinary metabolites
of icariin in vivo and estrogenic activities of its metabolites on
MCF-7 cells. Pharmazie 2005;60:120–5.
14. Jia DS, Jia X, Xue J, Shi F, Sun E, Chen L, et al. Study on
preparation of icaritin by enzymolysis of icariin with snail
hydrolase. China J Chin Mater Med 2010;35:857–60.15. Wang YL, Jia XB, Chen Y, Li X. Determination of equilibrium
solubility of icariin and its apparent oil/water partition coefﬁcient.
Chin J Tradit Chin Med Pharm 2008;23:777–9.
16. Vila Real HJ, Alfaia AJ, Calada ART, Ribeiro MHL. High
pressure-temperature effects on enzymatic activity: naringin
bioconversion. Food Chem 2007;102:565–70.
17. Ribeiro IAC, Ribeiro MHL. Kinetic modelling of naringin
hydrolysis using a bitter sweet alfa-rhamnopyranosidase immobi-
lized in k-carrageenan. J Mol Catal B Enzym 2008;51:10–8.
18. Cao A, Ai H, Ding Y, Dai C, Fei J. Biocompatible hybrid ﬁlm of
b-cyclodextrin and ionic liquids: a novel platform for electro-
chemical biosensing. Sens Actuators B Chem 2011;155:632–8.
19. Loftsson T, Brewster ME. Pharmaceutical applications of cyclo-
dextrins. 1. Drug solubilization and stabilization. J Pharm Sci
1996;85:1017–25.
20. Wang LJ, Zhu ZJ, Che KK, Ju FG. Characterization of micro-
structure of ibuprofen-hydroxypropyl-beta-cyclodextrin and ibu-
profen-beta-cyclodextrin by atomic force microscope. Acta Pharm
Sin 2008;43:969–73.
21. Wu PJ, Xu RC, Su ZT, Wei P, Lin YJ, Yang M, et al. The nasal
mucosa permeability and toxicity of baicalin carrier systems
liposomes, beta-cyclodextrin inclusion compound, and phospho-
lipid complex. Acta Pharm Sin 2009;44:417–24.
22. Manolikar MK, Sawant MR. Study of solubility of isoproturon
by its complexation with beta-cyclodextrin. Chemosphere 2003;51:
811–6.
23. Rawat S, Jain SK. Solubility enhancement of celecoxib using beta-
cyclodextrin inclusion complexes. Eur Pharm Biopharm 2004;57:
263–7.
24. Del Valle EMM. Cyclodextrins and their uses: a review. Process
Biochem 2004;39:1033–46.
25. Corti G, Capasso G, Maestrelli F, Cirri M, Mura P. Physical–
chemical characterization of binary systems of metformin hydro-
chloride with triacetyl-beta-cyclodextrin. J Pharm Biomed Anal
2007;45:480–6.
26. Higuchi T, Connors KA. Phase solubility techniques. Adv J Anal
Chem Instrum 1965;4:117–212.
27. Box G, Behnken D. Some new three level designs for the study of
quantitative variables. Technometrics 1960;2:455–75.
28. Hui J, Wu Y, Zhu CQ. The research and technology of Xinjiang
snail enzyme. J Xinjiang Norm Univ Nat Sci Ed 2006;25:91–2.
29. Kyung YY, Myeonghwa C, Seung RS, Kim KS. Enzymatic
production of a soluble-ﬁbre hydrolyzate from carrotpomace
and its sugar composition. Food Chem 2005;92:151–7.
30. Zeng XF, Chen SL, Li JG. Preparation of chitin and chitosan
oligosaccharide. Chin J Mar Drugs 1995;14:46–51.
31. Wang JH, Cai Z. Investigation of inclusion complex of micona-
zole nitrate with b-cyclodextrin. Carbohydr Polym 2008;72:255–60.
32. Ficarra R, Tommasini S, Raneri D, Calabr o ML, Di Bella MR,
Rustichelli C, et al. Study of ﬂavonoids/beta-cyclodextrins inclu-
sion complexes by NMR, FT-IR, DSC, X-ray investigation.
J Pharm Biomed Anal 2002;29:1005–14.
33. Hu Y, Fan Y, Xiao M, Zhou J, Lu Y, Yang Z, et al. Preparation
of arctigenin by enzymolysis of arctiin with snail hydrolase.
J Guangzhou Univ Tradit Chin Med 2004;21:473–5.
34. Zhang T, Wu CY, Zhang YM, Wang L. Study on chitooligosac-
charide production by chitosan hydrolysis with snailase. West
China J Pharm Sci 2010;25:313–5.
35. Liu X, Cui Y, Yang L, Yang SL. Puriﬁcation of a Ginsenoside-Rb1
hydrolase from Heli nailase. Chin J Biotechnol 2005;21:929–33.
36. Zhang J, Jin YJ, Wu ZL. Hydrolysis of chitosan with chitin
immobilized snailase. Polym Mater Sci Eng 2009;21:142–5.
37. Mizuno M, Iinuma M, Tanaka T. Flavonol glyeosides in the roots
of Epimedium diphyllum. Phytochemistry 1988;27:36–45.
38. Li F, Liu YL. Stydies on the isolations and structures of
baohuosids-I, VI, VII and baohuosu. Acta Pharm Sin 1988;23:
739–48.
